40 results
P
children
I/C
hormones, AEDs, AEDs alone
O
clinical improvement rate, seizure control, EEG abnormalities, cognition
P
HLA alleles
I/C
Antiepileptic drugs (AEDs), SJS/TEN
O
association between HLA and AED-induced SJS/TEN
P
HGG patients without a history of seizures
I/C
prophylactic antiepileptic drugs (AED), controls
O
incidence of postoperative seizures
P
patients with erectile dysfunction
I/C
combination of Pycnogenol ® and L-arginine (PAL), control group
O
improving sexual function
P
neonates
I/C
phenobarbitone, other anti-epileptic drugs (AEDs)
O
seizure control, adverse effects, neurodevelopmental outcomes
P
patients with COVID-19
I/C
diabetes, no diabetes
O
mortality
P
حُمَّى القرم-الكونجو النزفية
I/C
تزايد اتجاهات الانتشار, إنتشار
O
انتشار
P
insomnia
I/C
orexin receptor antagonists (ORAs), benzodiazepine-like drugs (Z-drugs), melatonin receptor agonists (MRAs), placebo
O
sleep latency (SL), awake time after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), sleep quality (SQ), adverse events (AED)
P
patellofemoral pain (PFP) patients
I/C
kinetic factors of dynamic knee valgus (DKV), healthy individuals
O
decrease co-contraction of gluteus medius (GMED) and adductors longus (AL), increase knee abduction moment, impulse, onset and during gluteus medius (GMED); vis-à-vis, decrease onset and during adductors longus (AL)
P
menopausal women
I/C
Fezolinetant, placebo
O
decrease in vasomotor symptoms frequency and severity, safety outcomes